The FDA (Food and Drug Association) approved drugs for the treatment of AD includes the administration of AChEIs (acetylcholinesterases inhibitors), NMDA (N-methyl-D-aspartate receptor antagonists) (Auld et al., 2002; Anand et al., 2014), Selegiline (used in the treatment of Parkinson’s Disorder) (Anand et al., 2014; Abeysinghe et al., 2020), estrogen therapy (Auld et al., 2002), NSAIDs (Non-Steroids Anti-Inflammatory Drugs) (Abeysinghe et al., 2020). Here, ACHE is linked to Alzheimer disease.